RNA Assays for Endometriosis Detection and Diagnosis

Enrolling by invitation

Conditions studied: Endometriosis

In brief

Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need therefore is an accurate biomarker that can be used to detect the disease early. This study is a prospective trial to identify candidate mRNA-markers which can be used to aid in the diagnosis of this disease. It is a discovery/validation study that will identify and confirm a gene expression panel that is specific for endometriosis and provides a non-invasive tool for future use.

Key facts

Study ID
NCT06907303
Run by
Wren Laboratories LLC
People needed
400
Starts
2024-01-01
Expected to finish
2026-12-31
Last updated by the study team
2025-04-02

Who can join

Age: 20 and older, up to 35. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.